Europe Biopsy Devices Market Forecast 2024-2032

The Europe biopsy devices market is forecasted to prosper at a CAGR of 7.85% over the forecast period of 2024-2032. The market growth is driven by several factors, including the rising prevalence of cancer, increasing demand for minimally invasive surgeries, and a surge in the number of hospitals and diagnostic centers.

MARKET INSIGHTS

The Europe biopsy devices market is observing sustained development due to advancements in healthcare technology and an increased emphasis on early disease detection. Biopsy devices, important for obtaining tissue samples, especially in cancer identification, are in high demand. The market presents a varied selection of biopsy devices, encompassing needle-based instruments, core biopsy devices, and vacuum-assisted biopsy systems. Furthermore, innovations in minimally invasive biopsy techniques and advanced imaging guidance systems are positive drivers. As a result, these factors are set to stimulate the market's growth in Europe during the forecast period.

However, the biopsy devices market in Europe faces challenges such as stringent regulatory requirements for product approvals and the high costs associated with developing and maintaining biopsy technologies. Economic uncertainties and budget constraints in healthcare spending across some European countries contribute to challenges in market expansion. Ongoing research and technological advancements are expected to shape the future of this critical healthcare sphere, overcoming restraints and ensuring its continued role in providing essential diagnostic solutions in the evolving healthcare domain of Europe. Despite challenges, the market is set for substantial growth in Europe over the forecast period.

COMPETITIVE INSIGHTS

Some of the major companies in the Europe biopsy devices market include: Cook Medical, Inrad Inc, DTR Medical, Cardinal Health, Argon Medical Devices, Boston Scientific, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 78664

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
- 2.4.1. IMPACT OF COVID-19 ON BIOPSY DEVICES MARKET
2.5. MAJOR MARKET FINDINGS
- 2.5.1. GROWING EMPHASIS ON PERSONALIZED MEDICINE
- 2.5.2. EXPANDING APPLICATIONS ACROSS MEDICAL SPECIALITIES
- 2.5.3. DEVELOPMENT OF COST-EFFECTIVE BIOPSY SOLUTIONS

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. RISING PREVALENCE OF CANCER
- 3.1.2. INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES
- 3.1.3. SURGE IN THE NUMBER OF HOSPITALS AND DIAGNOSTIC CENTERS
3.2. KEY RESTRAINTS
- 3.2.1. HIGH RISK OF INFECTION FOR PATIENTS
- 3.2.2. HIGH COST OF BIOPSY PROCEDURES
- 3.2.3. LACK OF SKILLED PROFESSIONALS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. SURGE IN THE HEALTHCARE EXPENDITURE
- 4.1.2. SHIFT TOWARDS PREVENTIVE HEALTHCARE
- 4.1.3. ADVANCEMENTS IN BIOPSY TECHNOLOGY
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTIONS
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.4. VALUE CHAIN ANALYSIS
- 4.4.1. RAW MATERIALS
- 4.4.2. MANUFACTURERS
- 4.4.3. DISTRIBUTION
- 4.4.4. END-USERS

5. MARKET BY PRODUCT

5.1. NEEDLE- BASED BIOPSY GUNS
- 5.1.1. VACUUM-ASSISTED BIOPSY (VAB) DEVICES
- 5.1.2. FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES
- 5.1.3. CORE NEEDLE BIOPSY (CNB) DEVICES
5.2. BIOPSY GUIDANCE SYSTEMS
5.3. BIOPSY NEEDLES
5.4. BIOPSY FORCEPS
5.5. OTHER PRODUCTS

6. MARKET BY APPLICATION

6.1. ONCOLOGY
6.2. GASTROENTEROLOGY
6.3. PULMONOLOGY
6.4. DERMATOLOGY
6.5. OTHER APPLICATIONS

7. MARKET BY END USE

7.1. HOSPITALS
7.2. AMBULATORY SURGICAL CENTERS
7.3. DIAGNOSTIC CENTERS

8. GEOGRAPHICAL ANALYSIS

8.1. EUROPE
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. EUROPE BIOPSY DEVICES MARKET DRIVERS
- 8.1.3. EUROPE BIOPSY DEVICES MARKET CHALLENGES
- 8.1.4. KEY PLAYERS IN EUROPE BIOPSY DEVICES MARKET
- 8.1.5. COUNTRY ANALYSIS
  - 8.1.5.1. UNITED KINGDOM
  - 8.1.5.2. GERMANY
  - 8.1.5.3. FRANCE
  - 8.1.5.4. ITALY
  - 8.1.5.5. SPAIN
  - 8.1.5.6. POLAND
  - 8.1.5.7. BELGIUM
  - 8.1.5.8. DENMARK
  - 8.1.5.9. REST OF EUROPE

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. CARDINAL HEALTH
- 9.2.2. HOLOGIC INC
- 9.2.3. DANAHER CORPORATION
- 9.2.4. CONMED CORPORATION
- 9.2.5. COOK MEDICAL
- 9.2.6. DTR MEDICAL
- 9.2.7. INRAD INC
- 9.2.8. BOSTON SCIENTIFIC
- 9.2.9. MEDTRONIC PLC
- 9.2.10. BECTON DICKINSON AND COMPANY
- 9.2.11. MAMMOTOME
- 9.2.12. ARGON MEDICAL DEVICES

Product Code: 78664

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - BIOPSY DEVICES
TABLE 2: EUROPE BIOPSY DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: EUROPE BIOPSY DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: EUROPE BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: EUROPE BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: EUROPE BIOPSY DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: EUROPE BIOPSY DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: EUROPE BIOPSY DEVICES MARKET, BY END USE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: EUROPE BIOPSY DEVICES MARKET, BY END USE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: EUROPE BIOPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: EUROPE BIOPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: KEY PLAYERS OPERATING IN EUROPE BIOPSY DEVICES MARKET
TABLE 13: LIST OF MERGERS & ACQUISITIONS
TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 15: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 16: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING
FIGURE 4: VALUE CHAIN ANALYSIS
FIGURE 5: EUROPE BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023
FIGURE 6: EUROPE BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, 2024-2032 (IN $ MILLION)
FIGURE 7: EUROPE BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY NEEDLE-BASED BIOPSY GUNS, IN 2023
FIGURE 8: EUROPE BIOPSY DEVICES MARKET, BY VACUUM-ASSISTED BIOPSY (VAB) DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 9: EUROPE BIOPSY DEVICES MARKET, BY FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 10: EUROPE BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY (CNB) DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 11: EUROPE BIOPSY DEVICES MARKET, BY BIOPSY GUIDANCE SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 12: EUROPE BIOPSY DEVICES MARKET, BY BIOPSY NEEDLES, 2024-2032 (IN $ MILLION)
FIGURE 13: EUROPE BIOPSY DEVICES MARKET, BY BIOPSY FORCEPS, 2024-2032 (IN $ MILLION)
FIGURE 14: EUROPE BIOPSY DEVICES MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)
FIGURE 15: EUROPE BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023
FIGURE 16: EUROPE BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 17: EUROPE BIOPSY DEVICES MARKET, BY GASTROENTEROLOGY, 2024-2032 (IN $ MILLION)
FIGURE 18: EUROPE BIOPSY DEVICES MARKET, BY PULMONOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 19: EUROPE BIOPSY DEVICES MARKET, BY DERMATOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 20: EUROPE BIOPSY DEVICES MARKET, BY OTHER APPLICATIONS, 2024-2032 (IN $ MILLION)
FIGURE 21: EUROPE BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY END USE, IN 2023
FIGURE 22: EUROPE BIOPSY DEVICES MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE 23: EUROPE BIOPSY DEVICES MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)
FIGURE 24: EUROPE BIOPSY DEVICES MARKET, BY DIAGNOSTIC CENTERS, 2024-2032 (IN $ MILLION)
FIGURE 25: EUROPE BIOPSY DEVICES MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 26: UNITED KINGDOM BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 27: GERMANY BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 28: FRANCE BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 29: ITALY BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 30: SPAIN BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 31: POLAND BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 32: BELGIUM BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 33: DENMARK BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 34: REST OF EUROPE BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)